Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1011260005Suspended
Randomised, double-blind trial of levobupivacaine in breast cancer (2 arms), sponsored by Asuka Pharmaceutical. Primary endpoint: Leakage Score at completion of sentinel lymph node biopsy. Started Jun 2026; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1011260005.